These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36538297)

  • 1. Bayesian estimation of post-test probability of Candida glabrata fungemia by means of serum creatinine.
    Leli C; Gotta F; Ferrara L; Scomparin E; Bona E; Ciriello MM; Rocchetti A
    New Microbiol; 2022 Dec; 45(4):324-330. PubMed ID: 36538297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients.
    Cohen Y; Karoubi P; Adrie C; Gauzit R; Marsepoil T; Zarka D; Clec'h C
    Crit Care Med; 2010 Mar; 38(3):826-30. PubMed ID: 20042858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011.
    Guinea J; Zaragoza Ó; Escribano P; Martín-Mazuelos E; Pemán J; Sánchez-Reus F; Cuenca-Estrella M;
    Antimicrob Agents Chemother; 2014; 58(3):1529-37. PubMed ID: 24366741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azole resistance of Candida glabrata in a case of recurrent fungemia.
    Posteraro B; Tumbarello M; La Sorda M; Spanu T; Trecarichi EM; De Bernardis F; Scoppettuolo G; Sanguinetti M; Fadda G
    J Clin Microbiol; 2006 Aug; 44(8):3046-7. PubMed ID: 16891541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal resistance to fluconazole and echinocandins is not emerging in yeast isolates causing fungemia in a Spanish tertiary care center.
    Marcos-Zambrano LJ; Escribano P; Sánchez C; Muñoz P; Bouza E; Guinea J
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4565-72. PubMed ID: 24867979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood stream infections by Candida glabrata and Candida krusei: a single-center experience.
    Choi HK; Jeong SJ; Lee HS; Chin BS; Choi SH; Han SH; Kim MS; Kim CO; Choi JY; Song YG; Kim JM
    Korean J Intern Med; 2009 Sep; 24(3):263-9. PubMed ID: 19721864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective Evaluation of fluconazole for the treatment of Candida glabrata fungemia.
    Wilson AG; Micek ST; Ritchie DJ
    Clin Ther; 2005 Aug; 27(8):1228-37. PubMed ID: 16199247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
    Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection.
    Klevay MJ; Ernst EJ; Hollanbaugh JL; Miller JG; Pfaller MA; Diekema DJ
    Diagn Microbiol Infect Dis; 2008 Mar; 60(3):273-7. PubMed ID: 18024053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candida glabrata fungemia: experience in a tertiary care center.
    Malani A; Hmoud J; Chiu L; Carver PL; Bielaczyc A; Kauffman CA
    Clin Infect Dis; 2005 Oct; 41(7):975-81. PubMed ID: 16142662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquisition of flucytosine, azole, and caspofungin resistance in Candida glabrata bloodstream isolates serially obtained from a hematopoietic stem cell transplant recipient.
    Chapeland-Leclerc F; Hennequin C; Papon N; Noël T; Girard A; Socié G; Ribaud P; Lacroix C
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1360-2. PubMed ID: 20038613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
    Ozcan SK; Mutlu B; Dündar D; Willke A
    Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
    Karabıçak N; Alem N
    Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in karyotype and azole susceptibility of sequential bloodstream isolates from patients with Candida glabrata candidemia.
    Shin JH; Chae MJ; Song JW; Jung SI; Cho D; Kee SJ; Kim SH; Shin MG; Suh SP; Ryang DW
    J Clin Microbiol; 2007 Aug; 45(8):2385-91. PubMed ID: 17581937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival in Patients with Candida glabrata Bloodstream Infection Is Associated with Fluconazole Dose.
    Eschenauer GA; Carver PL; Patel TS; Lin SW; Klinker KP; Pai MP; Lam SW
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29581112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candida glabrata fungaemia in intensive care units.
    Ruan SY; Lee LN; Jerng JS; Yu CJ; Hsueh PR
    Clin Microbiol Infect; 2008 Feb; 14(2):136-40. PubMed ID: 18042196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal resistance does not necessarily affect Candida glabrata fitness.
    Borghi E; Andreoni S; Cirasola D; Ricucci V; Sciota R; Morace G
    J Chemother; 2014 Feb; 26(1):32-6. PubMed ID: 24091025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triazole cross-resistance among Candida spp.: case report, occurrence among bloodstream isolates, and implications for antifungal therapy.
    Magill SS; Shields C; Sears CL; Choti M; Merz WG
    J Clin Microbiol; 2006 Feb; 44(2):529-35. PubMed ID: 16455909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update from a 12-Year Nationwide Fungemia Surveillance: Increasing Intrinsic and Acquired Resistance Causes Concern.
    Astvad KMT; Johansen HK; Røder BL; Rosenvinge FS; Knudsen JD; Lemming L; Schønheyder HC; Hare RK; Kristensen L; Nielsen L; Gertsen JB; Dzajic E; Pedersen M; Østergård C; Olesen B; Søndergaard TS; Arendrup MC
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29212705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and economic outcomes of decreased fluconazole susceptibility in patients with Candida glabrata bloodstream infections.
    Lee I; Morales KH; Zaoutis TE; Fishman NO; Nachamkin I; Lautenbach E
    Am J Infect Control; 2010 Nov; 38(9):740-5. PubMed ID: 20542354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.